ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats

被引:14
作者
Allahdadi, Kyan J. [1 ]
Walker, Benjimen R. [1 ]
Kanagy, Nancy L. [1 ]
机构
[1] Univ New Mexico, Dept Cell Biol & Physiol, Hlth Sci Ctr, Vasc Physiol Grp, Albuquerque, NM 87131 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2007年 / 293卷 / 05期
关键词
sleep apnea; endothelin-1; vascular smooth muscle cells; Rho-associated kinase;
D O I
10.1152/ajpheart.00217.2007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats. Am J Physiol Heart Circ Physiol 293: H2911-H2918, 2007. First published August 24, 2007; doi:10.1152/ajpheart.00217.2007. - We reported previously that intermittent hypoxia with CO2 to maintain eucapnia (IH-C) elevates plasma endothelin-1 (ET-1) and arterial pressure. In small mesenteric arteries (sMA; inner diameter = 150 mu m), IH-C augments ET-1 constrictor sensitivity but diminishes ET-1-induced increases in intracellular Ca2+ concentration, suggesting IH-C exposure increases both ET-1 levels and ET-1-stimulated Ca2+ sensitization. Because Rho-associated kinase ( ROK) can mediate Ca2+ sensitization, we hypothesized that augmented vasoconstrictor sensitivity to ET-1 in arteries from IH-C-exposed rats is dependent on ROK activation. In thoracic aortic rings, ET-1 contraction was not different between groups, but ROK inhibition (Y-27632, 3 and 10 mu M) attenuated ET-1 contraction more in IH-C than in sham arteries ( 50 +/- 11 and 78 +/- 7% vs. 41 +/- 12 and 48 +/- 9% inhibition, respectively). Therefore, ROK appears to contribute more to ET-1 contraction in IH-C than in sham aorta. In sMA, ROK inhibitors did not affect ET-1-mediated constriction in sham arteries and only modestly inhibited it in IH-C arteries. In ionomycin-permeabilized sMA with intracellular Ca2+ concentration held at basal levels, Y-27632 did not affect ET-1-mediated constriction in either IH-C or sham sMA and ET-1 did not stimulate ROK translocation. In contrast, inhibition of myosin light-chain kinase (ML-9, 100 mu M) prevented ET-1-mediated constriction in sMA from both groups. Therefore, IH-C exposure increases ET-1 vasoconstrictor sensitivity in sMA but not in aorta. Furthermore, ET-1 constriction is myosin light-chain kinase dependent and mediated by Ca2+ sensitization that is independent of ROK activation in sMA but not aorta. Thus ET-1-mediated signaling in aorta and sMA is altered by IH-C but is dependent on different second messenger systems in small vs. large arteries.
引用
收藏
页码:H2911 / H2918
页数:8
相关论文
共 42 条
[1]   Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension [J].
Allahdadi, KJ ;
Walker, BR ;
Kanagy, NL .
HYPERTENSION, 2005, 45 (04) :705-709
[2]   Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) [J].
Amano, M ;
Ito, M ;
Kimura, K ;
Fukata, Y ;
Chihara, K ;
Nakano, T ;
Matsuura, Y ;
Kaibuchi, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20246-20249
[3]  
Asano M, 2003, HYPERTENS RES, V26, P97
[4]   Segmental differences in the roles of rho-kinase and protein kinase C in mediating vasoconstriction [J].
Budzyn, K ;
Paull, M ;
Marley, PD ;
Sobey, CG .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (02) :791-796
[5]   Targeting Rho and Rho-kinase in the treatment of cardiovascular disease [J].
Budzyn, K ;
Marley, PD ;
Sobey, CG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (02) :97-104
[6]   Rho-kinase expression and its contribution to the control of perfusion pressure in the isolated rat mesenteric vascular bed [J].
Büyükafsar, K ;
Arikan, O ;
Ark, M ;
Seçilmis, A ;
Ün, I ;
Singirik, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 485 (1-3) :263-268
[7]   Acute and chronic NOS inhibition enhances α2-adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta [J].
Carter, RW ;
Begaye, M ;
Kanagy, NL .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (04) :H1361-H1369
[8]  
CARTER RW, 2003, BRIT J PHARMACOL, V284, pH309
[9]   RhoA/rho-kinase, vascular changes, and hypertension [J].
Chitaley K. ;
Weber D.S. ;
Webb R.C. .
Current Hypertension Reports, 2001, 3 (2) :139-144
[10]   Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein [J].
Claing, A ;
Shbaklo, H ;
Plante, M ;
Bkaily, G ;
D'Orléans-Juste, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (02) :433-443